拓新药业：关于子公司取得药品生产许可证的公告

Core Viewpoint - The company has received a production license for coenzyme Q10, indicating compliance for manufacturing [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd., has obtained a drug production license from the Henan Provincial Drug Administration [1] - The license number is Yu 20260007, and it is valid until February 12, 2031 [1] - The production scope includes the active pharmaceutical ingredient coenzyme Q10, marking the company's formal qualification for compliant production [1]